NORTHERN TRUST CORP - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 50 filers reported holding SUMMIT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,998,093
-22.7%
1,068,499
+3.7%
0.00%
Q2 2023$2,585,405
+2117.2%
1,030,042
+1445.8%
0.00%
Q1 2023$116,608
-45.7%
66,633
+32.0%
0.00%
Q4 2022$214,600
+694.8%
50,494
+120.5%
0.00%
Q3 2022$27,000
-93.7%
22,903
-87.0%
0.00%
Q1 2022$431,000
-16.8%
175,682
-8.9%
0.00%
Q4 2021$518,000
-46.7%
192,802
-0.7%
0.00%
Q3 2021$972,000
+279.7%
194,066
+466.5%
0.00%
Q2 2021$256,00034,2550.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Alpine Global Management, LLC 0$760,0000.09%
Polar Capital Holdings Plc 6,272,509$15,368,0000.07%
VANCE WEALTH, INC. 13,299$33,0000.04%
Inscription Capital, LLC 17,000$42,0000.01%
LEVIN CAPITAL STRATEGIES, L.P. 44,176$108,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 154,950$380,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 129,100$316,0000.01%
HoyleCohen, LLC 15,432$38,0000.00%
ADIRONDACK TRUST CO 2,500$6,0000.00%
Baillie Gifford 436,512$1,070,0000.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders